An immunocytochemical investigation of human trigeminal nucleus caudalis: CGRP, substance P and 5-HT1D-receptor immunoreactivities are expressed by trigeminal sensory fibres

Cephalalgia

Volumn 22, Issue 6, 2002, Pages 424-431

  Smith, D ^a   Hill, R G ^a   Edvinsson, L ^b   Longmore, J ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

5 HT1D receptors; Calcitonin gene related peptide; Human brainstem; Migraine; Substance P

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NEUROPEPTIDE; SEROTONIN; SEROTONIN 1D AGONIST; SEROTONIN 1D RECEPTOR; SUBSTANCE P; SEROTONIN RECEPTOR;

ARTICLE; BRAIN STEM; CRANIAL PAIN; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MIGRAINE; PAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; SENSORY NERVE; TRIGEMINAL NERVE; TRIGEMINAL NUCLEUS; TRIGEMINAL NUCLEUS CAUDALIS; HISTOLOGY; METABOLISM; NERVE FIBER;

CALCITONIN GENE-RELATED PEPTIDE; HUMANS; IMMUNOHISTOCHEMISTRY; NERVE FIBERS; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, SEROTONIN; SUBSTANCE P; TRIGEMINAL CAUDAL NUCLEUS;

EID: 0036632586     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2002.00378.x     Document Type: Article

References (36)

1. Feindel W, Penfield W, McNaughton F. The tentoral nerves and localisation of intracranial pain in man. Neurol 1960; 10:555-63.
2. Martins IP, Baeta E, Paiva T, Campo T, Gomes L. Headaches during intracranial endovascular procedures: a possible model of vascular headache. Headache 1993; 33:227-33.
3. Friberg L, Olesen J, Iversen HK, Sperling B. Migraine pain associated with middle cerebral artery dilation: reversal by sumatriptan. Lancet 1991; 338:13-17.
4. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993; 33:48-56.
5. Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL. Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat. Cephalalgia 1997; 17:518-24.
6. Kurosawa M, Messlinger K, Pawlak M, Schmidt RF. Increase in meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide. Br J Pharmacol 1995; 114:1397-402.
7. Cumberbatch MJ, Hill RG, Hargreaves RJ. Rizatriptan has central antinociceptive effects against durally evoked responses. Eur J Pharmacol 1997; 328:37-40.
8. Buzzi MG, Moskowitz MA. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 1990; 99:202-6.
9. Shepheard SL, Williamson DJ, Williams J, Hill RG, Hargreaves RJ. Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma protein extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacol 1995; 34:255-61.
10. 1B/1D receptor agonists on neurogenic dural plasma protein extravasation and vasodilation in anaesthetized rats. Neuropharmacol 1997; 36:525-33.
11. Longmore J, Dowson AJ, Hill RG. Advances in migraine therapy - 5-HT receptor subtype specific agonists. Curr Opin CPNS Invest Drugs 1999; 1:39-53.
12. 1B receptor by subtypes of rat trigeminal ganglion cells. Neurosci 2000; 95:465-71.
13. 1D receptor mRNA differential co-localization with peptide mRNA in the guinea-pig trigeminal ganglion. Neuroreport 1998; 9:641-5.
14. 1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalalgia 1997; 17:833-42.
15. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin fixed paraffin embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39:741-8.
16. Martin JH, Jessell TM. Modality coding in the somatic sensory system. In: Kandel ER, Schwatz JH, Jessell TM, editors. Principles of neural science. New York: Elsevier, 1993:341-52.
17. 1B receptors in the human trigeminal ganglion: co-localisation with calcitonin gene-related peptide, substance P and nitric oxide synthase. Br Res 2001; 909:112-20.
18. 1D agonist. Cephalalgia 2000; 20:268.
19. 1D-selective ligands). Br J Pharmacol 1999; 127:468-72.
20. Edvinsson L, Goadsby PJ. Neuropeptides in headache. Eur J Neurol 1998; 5:329-41.
21. Goldstein DJ, Wang O, Saper JS, Stolz R, Silberstein SD, Mathew NT. Ineffectiveness of neurokinin-1 antagonist in acute migraine. Cephalalgia 1997; 17:785-90.
22. Goldstein DJ. Is there a role for NK-1 antagonists in migraine? Presented at IBC Migraine Conference, Philadelphia, April, 1999.
23. Connor HE, Bertin L, Gillies S, Beattie DT, Ward P and the GR205171 Clinical Study Group. Clinical evaluation of a novel, potent, CNS penetrating NK, receptor antagonist in the acute treatment of migraine. Cephalalgia 1998; 18:392.
24. Doods H, Hallermayer G, Dongmei W, Entzeroth M, Rudolf K, Engel W et al. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol 2000; 129:420-3.
25. Marukawa H, Shimomura T, Takahashi K. Salivary substance P, 5-hydroxytryptamine, and γ-aminobutyric acid levels in migraine and tension-type headache. Headache 1996; 36:100-4.
26. Stittermatter M, Grauer M, Isenberg E, Hamann G, Fischer C, Hoffmann K-H et al. Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia. Headache 1997; 37:211-6.
27. Cady RK, Gutterman D, Saiers JA, Beach ME. Responsiveness of non-IHS migraine and tension-type headache to sumatriptan. Cephalalgia 1997; 17:588-90.
28. Davis KD, Dostrovsky JO. Properties of feline thalamic neurons activated by stimulation of the middle meningeal artery and sagittal sinus. Brain Res 1988; 454:89-100.
29. Sjoqvist J. Studies on the pain conduction in the trigeminal nerve. A contribution to surgical treatment of facial pain. Acta Psychiatr Scand [(Suppl)] 1938; 17:1139.
30. Usunoff KG, Marani E, Schoen JHR. The trigeminal system in man. Ad Anat Embryol Cell Biol 1997; 136:1-126.
31. Uddman R, Edvinsson L, Ekman R, Kingman T, McCulloch J. Innervation of the feline cerebral vasculature by nerve fibres containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Letts 1985; 62:131-6.
32. Hanko J, Hardebo J, Kahrstrom J, Owman CH, Sundler F. Existence and co-existence of calcitonin gene-related peptide (CGRP) and substance P in cerebrovascular nerves and trigeminal ganglion cells. Acta Physiol Scand 1986; 127 (Suppl. 552):29-32.
33. Lawson SN, Crepps BA, Perl ER. Relationship of substance P to afferent characteristics of dorsal root ganglion neurones in guinea-pig. J Physiol 1997; 505:177-91.
34. Tajti J, Uddman R, Moller S, Sundler F, Edvinsson L. Messenger molecules and receptor mRNA in the human trigeminal ganglion. J Auton Nerv Syst 1999; 76:176-83.
35. Li JL, Kaneko T, Shigemoto R, Mizuno N. Distribution of trigeminohypothalamic and spinohypothalamic tract neurons displaying substance P receptor-like immunoreactivity in the rat. J Comp Neurol 1997; 378:508-21.
36. 1B/1D agonist. Br J Pharmacol 1999; 126:1478-86.